MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pacira BioSciences

< Previous 1 2 3 4 5 Next >
News headline image
Pacira BioSciences Reports First Quarter 2025 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report 2024 Financial Results on Thursday February 27, 2025
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Announces Updates to Board of Directors
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Awarded New U.S. Patent Covering EXPAREL Composition
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira BioSciences Reports Third Quarter 2024 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
News headline image
Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story